Personalis shares rose after the company received Medicare coverage for its NeXT Personal molecular residual disease test for surveillance of patients with Stage I to III non-small cell lung cancer.

BBI WBC Rosters Baseball FILE - New York Mets' Francisco Lindor walks to the dugout during a baseball game against the Miami Marlins, Saturday, Sept. 27, 2025, in ...

TOKYO, Feb 2 (Reuters) - Japan's government said on Monday that it has successfully retrieved rare-earth-rich seabed mud for the first time from depths of around 6 km (4 miles) during a test mission.

We look at the new test from the IIHS and compare the first 18 small SUVs it tested to our rankings. As vehicles get heavier, the energy transfer in vehicle-to-vehicle crashes increases equally. This ...

Engineers in Silicon Valley have been raving about Anthropic’s AI coding tool, Claude Code, for months. But recently, the buzz feels as if it’s reached a fever pitch. Earlier this week, I sat down ...

On Friday, OpenAI announced it will begin testing advertisements inside the ChatGPT app for some US users in a bid to expand its customer base and diversify revenue. The move represents a reversal for ...

Replit's new feature allows users to create publishable and monetizable mobile apps using only natural language prompts. As more vibe-coding products come online, some software companies could see one ...

On Monday, Anthropic announced a new tool called Cowork, designed as a more accessible version of Claude Code. Built into the Claude Desktop app, the new tool lets users designate a specific folder ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

Anthropic has launched a beta integration that connects its fast-growing Claude Code programming agent directly into Slack, allowing software engineers to delegate coding tasks without leaving the ...

Is it three steps forward, one step back for blood tests? At the 18th Clinical Trials on Alzheimer’s Disease, held December 1–4 in San Diego, new data on the FDA-approved Fujirebio Lumipulse plasma ...